J Genet Med.  2020 Jun;17(1):39-42. 10.5734/JGM.2020.17.1.39.

Clinical features of Senior–Loken syndrome with IQCB1/NPHP5 mutation in a Filipino man

• Chiu HHC
• Sucaldito MSFP
• Maceda EBG
• Montemaor JAS
• Tamondong-Lachica DR

• KMID: 2503610
• DOI: http://doi.org/10.5734/JGM.2020.17.1.39

Abstract

The Senior–Loken syndrome was first described in 1961 as an oculo-renal disease consisting of familial juvenile nephronophthisis and Leber congenital amaurosis. It is a rare autosomal recessive disorder with a prevalence of 1:1,000,000 caused by mutations in nine genes (NPHP 1-8 and NPHP 10). Ocular manifestations (e.g., photophobia, nystagmus, and extreme hyperopia) occur within the first few years of life while renal manifestations (e.g., formation of multiple cysts impairing kidney function and end-stage renal disease) appear in late childhood to adolescence. Here, we report a case of a Filipino male presenting with rotatory nystagmus and progressive deterioration of vision since childhood. He had congenital amaurosis and juvenile nephronophthisis that progressed to end stage renal disease by age 19. All laboratory and imaging findings were consistent with chronic kidney disease. Molecular genetic testing of ciliopathy-related genes was performed revealing a homozygous mutation in exon 11 of the IQCB1/NPHP5 gene, c.1090C>T (p.Arg364*). This sequence change created a premature translational stop signal resulting in a truncated protein product, nephrocystin-5 and its consequent loss of function. His symptoms eventually improved with initiation dialysis. The prognosis of Senior–Loken syndrome remains dismal and a high index of suspicion, early diagnosis and timely intervention of renal complications are warranted.

Keyword

Ciliopathies; IQCB1 protein; human; Leber congenital amaurosis; Nephronophthisis; familial juvenil; Senior Loken syndrome